Integra Lifesciences Holdings (IART) EPS (Weighted Average and Diluted) (2016 - 2025)
Integra Lifesciences Holdings (IART) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with -$0.02 as the latest value for Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) fell 108.0% to -$0.02 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.73 through Dec 2025, down 7377.78% year-over-year, with the annual reading at -$6.74 for FY2025, 7388.89% down from the prior year.
- EPS (Weighted Average and Diluted) hit -$0.02 in Q4 2025 for Integra Lifesciences Holdings, up from -$0.07 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.63 in Q4 2022 to a low of -$6.31 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.09 across 5 years, with a median of $0.25 in 2023.
- Biggest five-year swings in EPS (Weighted Average and Diluted): soared 9511.78% in 2021 and later plummeted 3843.75% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at $0.53 in 2021, then increased by 18.87% to $0.63 in 2022, then crashed by 60.32% to $0.25 in 2023, then changed by 0.0% to $0.25 in 2024, then crashed by 108.0% to -$0.02 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for IART at -$0.02 in Q4 2025, -$0.07 in Q3 2025, and -$6.31 in Q2 2025.